•  
  •  
 

Corresponding Author

Hasan M. Agha

Authors ORCID

Hasan M. Agha: https://orcid.org/0000-0002-6637-2072

Amjad Abdulhadi Mohammed: https://orcid.org/0000-0002-5821-7523

Abstract

Regenerative medicine is a multidisciplinary domain focused on restoring, repairing, or replacing damaged tissues and organs by harnessing the body’s inherent healing abilities with sophisticated biological and technical techniques. Mesenchymal stem cells (MSCs) have become fundamental among many stem cell types because to their self-renewal, multipotency, paracrine signaling, and immunomodulatory capabilities. Their therapeutic adaptability has been shown in orthopedic, cardiovascular, neurological, dermatological, and immune-mediated illnesses, underscoring their clinical significance. Nonetheless, obstacles like donor heterogeneity, senescence during in vitro growth, restricted engraftment, and regulatory impediments persist in limiting repeatability and broad clinical use. Recent advancements are enhancing the capabilities of MSCs by using biomaterials, genetic modification, and cell-free methodologies, including MSC-derived extracellular vesicles. An intriguing domain is the interplay between MSCs and bioactive peptides, which can enhance cell adhesion, survival, differentiation, and targeted regenerative outcomes. This brief review outlines the fundamental principles of regenerative medicine, summarizes the unique attributes and therapeutic applications of MSCs, and highlights novel approaches that may overcome current limitations. These improvements collectively position MSCs as essentil catalysts for the next generation of regenerative therapies.

Digital Object Identifier (DOI)

10.70176/3007-973X.1042

Download

Share

COinS